Mojirade James compensation by year
AVANOS MEDICAL Summary Compensation Table · all 3 fiscal years held| Component | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Salary | $457,500 | $471,500 | $474,992 |
| Bonus | $0 | $0 | — |
| Stock awards | $1,175,187 | $1,175,000 | $1,081,250 |
| Option awards | $0 | $0 | $293,750 |
| Non-equity incentive | $232,502 | $230,429 | $265,479 |
| Pension and deferred compensation | $0 | $0 | — |
| All other | $38,663 | $36,292 | $34,123 |
| Total | $1,903,852 | $1,913,221 | $2,149,595 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: AVANOS MEDICAL, INC. DEF 14A filed March 12, 2026, accession 0001104659-26-027106, and prior-year filings. Open the filing on EDGAR.
How this page was built: the AVANOS MEDICAL, INC. filed document, accession 0001104659-26-027106. Every figure is read from that document and cited to the page and table it appears in. Filed March 12, 2026.
Equity holdings
unvested awards at FY2025 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| PSU | 38,401 | $431,243 | — |
| PSU | 31,084 | $349,073 | — |
| PSU | 17,167 | $192,785 | — |
| Option | 41,199 | — | $15.24 |
Per the Outstanding Equity Awards at Fiscal Year-End table in AVANOS MEDICAL, INC.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.
Change-in-control & termination
estimated payments AVANOS MEDICAL discloses, by trigger · FY2023| Trigger | Cash severance | Accelerated equity | Benefits continuation | Total as disclosed |
|---|---|---|---|---|
| Change in control and involuntary termination | $1,380,000 | $1,594,952 | $26,571 | $3,078,851 |
| Involuntary termination without cause | $1,380,000 | — | $12,862 | $1,392,862 |
| Death | $1,122,502 | $674,377 | $0 | $1,796,879 |
| Disability | $232,502 | $674,377 | $0 | $906,879 |
Per the Potential Payments Upon Termination or Change in Control table in AVANOS MEDICAL, INC.'s FY2023 proxy. Estimates as the company printed them; a dash means it printed no figure.
AVANOS MEDICAL’s named executive officers, FY2025
as the company reported each| Named executive officer | Role | FY2025 total |
|---|---|---|
| David Pacitti | Chief Executive Officer | $9,469,803 |
| Michael Greiner | Former Interim Chief Executive Officer | $5,283,109 |
| Kerr Holbrook | Former Senior Vice President and Chief Commercial Officer | $2,236,834 |
| Mojirade James · this page | Former Senior Vice President, General Counsel and Secretary | $2,149,595 |
| Scott Galovan | Senior Vice President, Chief Financial Officer | $2,039,138 |
| Sigfrido Delgado | Senior Vice President, Operations | $1,722,819 |
| Jason Pickett | Interim Chief Financial Officer | $1,321,118 |
| Warren Machan | Former Interim Chief Financial Officer | $405,000 |
Mojirade James's compensation dossier, AVANOS MEDICAL
You have read Mojirade James's totals and holdings. The dossier adds each equity grant AVANOS MEDICAL disclosed for Mojirade James and AVANOS MEDICAL's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.
See an example →The full AVANOS MEDICAL compensation record
free company briefThis page is one person within AVANOS MEDICAL's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the AVANOS MEDICAL proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order AVANOS MEDICAL's full Executive Compensation Report with peer benchmarking.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are AVANOS MEDICAL's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.
Order AVNS
Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.